WASHINGTON, D.C. – (February 15, 2022) – Matt Eyles, President and CEO of AHIP, issued this statement following the confirmation of Dr. Robert Califf as Commissioner of the Food and Drug Administration (FDA):
“Every American deserves affordable access to high-quality coverage and care, including the lifesaving prescription drugs and devices that are so important to millions of Americans.
“Dr. Califf is a skilled and experienced leader, and we congratulate him as he once again takes the helm of the FDA. This agency plays an essential role in safeguarding the health and well-being of Americans, including their access to effective and safe medications and devices. As new drugs come to market, including biologics that represent a new frontier for treatment and cures, the FDA will play an important role in analyzing clinical evidence and ensuring that drug manufacturers bring to market medicines that are proven to work. AHIP looks forward to working with Dr. Califf and the FDA to ensure that every American has access to the affordable, safe, and effective medications they need and deserve.”
About AHIP
AHIP is the national association whose members provide health care coverage, services, and solutions to hundreds of millions of Americans every day. We are committed to market-based solutions and public-private partnerships that make health care better and coverage more affordable and accessible for everyone. Visit www.ahip.org to learn how working together, we are Guiding Greater Health.